Form 4: Solid Biosciences CFO Kevin Tan Reports Stock Transactions

Kevin Tan, CFO & Treasurer of Solid Biosciences Inc., reports the acquisition and disposal of common stock and restricted stock units.

Summary

• Kevin Tan, the CFO & Treasurer of Solid Biosciences Inc., filed a Form 4 detailing changes in beneficial ownership.
• On February 13, 2025, Mr. Tan acquired 10,625 shares of common stock through the vesting of restricted stock units (RSUs).
• On February 14, 2025, Mr. Tan sold 3,164 shares of common stock at a price of $3.96 per share.
• The sale was to cover withholding taxes following the vesting of RSUs and was executed according to a pre-arranged plan adopted on August 15, 2024.
• Following these transactions, Mr. Tan directly owns 32,250 shares of common stock and 31,875 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, as it's simply a report of factual events.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is common in the biotechnology industry. It provides transparency into the trading activities of key personnel.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in insider ownership.
• The sale of shares to cover taxes is a routine event and unlikely to significantly affect stakeholder confidence.

Key Dates